Indicated for: hemorrhoids; anorectal inflammation and pain
Route of administration: rectal
Substance: bufexamac + bismuth subgallate + titanium dioxide + lidocaine (local anti-inflammatory, astringents and local anesthetic)
ATC: C05AX03 (Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Other agents for treatment of hemorrhoids and anal fissures for topical use)
Use during pregnancy only on medical advice.
Bufexamac + bismuth subgallate + titanium dioxide + lidocaine is a local combination used around the anal area to relieve symptoms of haemorrhoids, fissures or anorectal irritation. Bufexamac has anti-inflammatory action, lidocaine reduces pain and itching through local anaesthesia, and bismuth subgallate with titanium dioxide forms a protective layer on irritated skin and mucosa.
The product is applied locally, usually after cleaning the area and after bowel movements, according to the leaflet or the doctor’s advice. It should not be inserted or applied more often than directed. Treatment is intended for short-term use. If pain, bleeding, lumps, discharge or itching persist, worsen or recur frequently, a medical examination is needed to exclude other causes.
Possible side effects include stinging, redness, irritation, dryness, burning sensation or local allergic reactions. Bufexamac has been associated with allergic contact dermatitis, sometimes severe; for this reason, its use has been restricted or withdrawn in some countries. Lidocaine may rarely cause excessive numbness, irritation or allergy, especially when used on damaged skin.
Stop using the medicine and contact a doctor if rash, swelling, worsening itching, severe pain, rectal bleeding, fever or signs of infection occur. Do not use it on deep wounds unless advised. During pregnancy, breastfeeding, in children or in people allergic to local anaesthetics, it should be used only after medical advice.